Trial intelligence / Profile preview

Deferiprone in Parkinson's Disease

NCT01539837Phase 2Completed

Sponsor
Imperial College London
Start
Feb 2012
Primary completion
Sep 2014
Countries
1
01

Overview

A Phase 2 trial of deferiprone in Parkinson's disease (PD), sponsored by Imperial College London. Started Feb 2012; status: completed.

02

Drugs

deferiprone
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT01539837.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01539837.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call